In line with the ESC mission, newly presented content is made available to all for a limited time (4 months for ESC Congress, 3 months for other events). ESC Professional Members, Association Members (Ivory & above) benefit from year-round access to all the resources from their respective Association, and to all content from previous years. Fellows of the ESC (FESC), and Professionals in training or under 40 years old, who subscribed to a Young Combined Membership package benefit from access to all ESC 365 content from all events, all editions, all year long. Find out more about ESC Memberships here.
Effect of primary cardiovascular prevention on the prevalence of metabolic syndrome
1IRCCS Foundation Salvatore Maugeri, Department of Cardiology - Tradate - Italy
Purpose Metabolic syndrome (MS) is strongly related to cardiovascular events. We tested if the prevalence of MS was reduced in the otupatients referred to our primary cardiovascular prevention programme.
Methods Aims of primary cardiovascular prevention programmes are to control risk factors, to improve adherence to healthy behaviour and therapy and to prescribe targeted diagnostic evaluation. Visits at baseline and control at 1 year were performed. Counselling on diet and physical activity were given. Optimization of therapy was attempted and diagnostic tests were proposed. IDF and NCEPT ATP III definitions of MS were considered. In the outpatients referred to our primary cardiovascular prevention programme (66 women and 80 males) prevalence of MS and its determinants at baseline and 1 year were compared.
Results Diagnosis of MS was impossible in 7 women and 4 men at baseline and in 4 women and 3 men at 1 year according to IDF criteria and in 5 women and 4 men at baseline and 4 women and 3 men at 1 year according to NCEPT ATP III criteria. At 1 year a significant improvement in HDL and diastolic blood pressure control and a reduction of the prevalence of MS according to NCEPT ATP III criteria in whole population (p 0,04) and in women (p 0,03) and to IDF criteria in men (p 0,04) were achieved. Results are resumed in table 1.
Conclusion In patients referred to primary cardiovascular prevention programme a significant improvement of HDL cholesterol and diastolic blood pressure control was achieved. Prevalence of MS was significantly reduced in total population and in women according to NCEPT ATP III and in men according to IDF criteria.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease